from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3695/-

LFCtreatmentdescriptionclass of inhibitor

-0.068

Amikacinug/mL Amikacintranslation

1.198

Cap5-10ug/mL Capreomycintranslation

0.324

Rox10-50 ug/mL Roxithromycintranslation

0.534

SM2-5 ug/mL Streptomycintranslation

0.991

Tet5-10 ug/mL Tetracyclinetranslation

-0.453

Rif0.2-5ug/mL Rifampicintranscription

-0.341

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.459

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.166

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.566

CPZ10-50 ug/mL Chlorpromazinerespiration

0.714

Clofazimine10-13 ug/mL Clofaziminerespiration

0.522

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.636

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.991

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.241

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.087

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.402

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.083

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.164

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.044

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.712

KCN5-20 ug/mL Potassium cyaniderespiration

0.736

NaN30.2-2 mM Sodium aziderespiration

1.074

Nigericin50 uM Nigericinrespiration

-0.568

TRC10-150 ug/mL Triclosanrespiration

0.606

TRZ10-25 ug/mL Thioridazinerespiration

0.924

Valinomycin0.5-10 uM Valinomycinrespiration

-1.834

ZnSO42 mM ZnSO4respiration

0.824

menadione6-10 ug/mL Menadionerespiration

0.400

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.162

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.291

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.169

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.464

NRP_1Non-replicating persistence stage 1dosRassociated

0.503

Amp0.2mg/mL AmpicillincellWall

0.230

Cephalexin20-100 ug/mL CephalexincellWall

0.963

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.682

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.037

EMB10-20 ug/mL EthambutolcellWall

0.783

Eta12-40 ug/mL EthionamidecellWall

1.262

INH0.2-0.4 ug/mL IsoniazidcellWall

0.173

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.117

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.286

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.073

BZA0.12 mg/mL BenzamidearomaticAmides

-0.948

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.498

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.258

H2O24 mM hydrogen peroxideDNAdamaging

-0.023

Levo10 ug/mL LevofloxacinDNAdamaging

-0.575

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.438

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.324

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.584

UVUV-irradiationDNAdamaging

0.944

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.353

Antimycin12.5-50 ug/mL Antimycin A?

0.111

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.041

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.365

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.689

PA8240.2-2 ug/mL PA-824?

0.239

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.155

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.787

Verapamil50 uM Verapamil?

-0.155

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.559

methoxatin10-20 ug/mL Methoxatin?